Funded Startups in Herefordshire
Within the 13 disclosed rounds shown, Motor Fuel Group’s $664M (2025-08-04) is a clear size outlier: the next-largest disclosed amount is Mindtech’s $6M (2…
Within the 13 disclosed rounds shown, Motor Fuel Group’s $664M (2025-08-04) is a clear size outlier: the next-largest disclosed amount is Mindtech’s $6M (2024-10-16), with no other round above the single-digit millions. Sector-wise, biotechnology dominates the list, appearing in 6 of 13 entries (Laverock Therapeutics on 2026-06-01 at $3M; HQ Science Ltd. on 2024-12-01 at $260K; Freeline on 2022-03-10 at $26M; NeRRe Therapeutics on 2021-07-07 at $28M; Gyroscope Therapeutics on 2021-03-26 at $149M; Myricx Pharma on 2020-11-16 at $5M; ReViral on 2020-08-25 at $44M).
Geographically, the rounds cluster around Stevenage and Hereford: 7 of 13 entries list Stevenage (including the largest round at Motor Fuel Group in Hereford, Herefordshire, and multiple biotech rounds dated 2020–2022), while Hereford-based entries include Mindtech (2024-10-16 at $6M) and Vanguard Tech (2024-05-13 at $1M). Temporally, the table spans 2020-08-25 (ReViral at $44M) through 2026-06-01 (Laverock Therapeutics at $3M), with the most recent 3 disclosed rounds all occurring between 2025-06-09 and 2026-06-01. Also, “Series Unknown” appears in 5 of 13 rows (Laverock Therapeutics, Motor Fuel Group, Ruly, HQ Science Ltd., and Myricx Pharma).
Most recent rounds
13 shownRelated listings
Frequently asked
Which round sizes stand out, and how far ahead is the largest disclosed amount?
Motor Fuel Group’s $664M (2025-08-04) is the largest disclosed round; the next-largest disclosed amount in the table is Mindtech’s $6M (2024-10-16). This makes the top round dwarf the rest by at least an order-of-magnitude scale difference versus the remaining disclosed amounts.
Do biotech companies account for a meaningful share of this Herefordshire list?
Yes. Biotechnology appears in 6 of 13 entries: Laverock Therapeutics ($3M, 2026-06-01), HQ Science Ltd. ($260K, 2024-12-01), Freeline ($26M, 2022-03-10), NeRRe Therapeutics ($28M, 2021-07-07), Gyroscope Therapeutics ($149M, 2021-03-26), Myricx Pharma ($5M, 2020-11-16), and ReViral ($44M, 2020-08-25).
Where do the companies cluster geographically within the rows shown?
Stevenage and Hereford dominate the address pattern. Stevenage is listed for 7 entries (including multiple biotech companies dated 2020–2022), while Hereford shows up for Mindtech ($6M, 2024-10-16) and Stokly ($90K, 2022-05-09), and “Hereford, Herefordshire” is also where Motor Fuel Group is located ($664M, 2025-08-04).
What does the stage mix look like, and how much is “Series Unknown”?
There are multiple stage labels, but “Series Unknown” is present in 5 of 13 rows (Laverock Therapeutics $3M on 2026-06-01; Motor Fuel Group $664M on 2025-08-04; Ruly $680K on 2025-06-09; HQ Science Ltd. $260K on 2024-12-01; and Myricx Pharma $5M on 2020-11-16). Visible named stages include Seed for Vanguard Tech ($1M, 2024-05-13) and Series C for Gyroscope Therapeutics ($149M, 2021-03-26).
Which entries fall within the most recent date window in this table?
The most recent 90-ish day slice is represented by late-stage 2025–mid/late 2026 dates: Motor Fuel Group ($664M, 2025-08-04), Ruly ($680K, 2025-06-09), and Laverock Therapeutics ($3M, 2026-06-01) are the newest entries in the list. The table’s latest date is 2026-06-01 (Laverock Therapeutics) and the earliest is 2020-08-25 (ReViral).
Are there any smaller-ticket rounds that sharply contrast with the dominant size?
Yes. The smallest disclosed amount is HQ Science Ltd.’s $260K (2024-12-01), which is far below the next smallest disclosed amounts like Stokly’s $90K (2022-05-09) and contrasts strongly with the largest disclosed $664M (Motor Fuel Group, 2025-08-04). This creates a wide disclosed-amount spread even without counting any rows with blank “Series” classifications.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.